Insider Trading History of Hamill John P.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hamill John P. since 2019. This trader's CIK number is 1716213. At the time of last reporting, Hamill John P. was the SrVP/CFO/Prin Fin & Acct Ofcr of Aprea Therapeutics, Inc.. (stock ticker symbol APRE). Also see all insider trading activities at Aprea Therapeutics, Inc..

Note that in the past Hamill John P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Windtree Therapeutics Inc /de/ (WINT) by Hamill John P.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 WINT 3,000 $1,101 0 $0 0 $0
2021 WINT 2,500 $6,942 0 $0 0 $0
2020 WINT 1,000 $5,270 0 $0 0 $0

Yearly summary of insider trading at Trevena Inc (TRVN) by Hamill John P.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 TRVN 7,500 $8,700 0 $0 0 $0

Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Hamill John P.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 APRE 1,510 $8,659 0 $0 0 $0


Insider trading activities at 3 companies by Hamill John P.:

1. Windtree Therapeutics Inc /de/ (WINT)

2. Trevena Inc (TRVN)

3. Aprea Therapeutics, Inc. (APRE)

Table 1. Insider trading of Windtree Therapeutics Inc /de/ (WINT) by Hamill John P.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-07-26 WINT Buy 3,000 .37 1,101
2021-04-16 WINT Buy 1,000 2.07 2,067
2021-03-25 WINT Buy 1,500 3.25 4,875
2020-10-07 WINT Buy 1,000 5.27 5,270

Table 2. Insider trading of Trevena Inc (TRVN) by Hamill John P.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-31 TRVN Buy 7,500 1.16 8,700

Table 3. Insider trading of Aprea Therapeutics, Inc. (APRE) by Hamill John P.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-10-11 APRE Buy 50 2.46 123
2024-10-10 APRE Buy 450 2.61 1,174
2024-03-13 APRE Buy 1,010 7.29 7,362

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hamill John P. (SrVP/CFO/Prin Fin & Acct Ofcr of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.